Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine

Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine A double‐blind 12 week trial was undertaken to compare the effects of clomipramine + dixyrazine with clomipramine + placebo in the treatment of panic disorder with or without agoraphobia. Of 45 patients included (21 dixyrazine, 24 placebo), 16 dropped out (6 dixyrazine, 10 placebo). The number of panic attacks and the scores on the panic disorder subscale of the Hamilton Anxiety Rating Scale were significantly reduced in response to both treatment regimens, but the reduction was significantly greater in the dixyrazine group. The patients’ daily functioning was significantly more improved with the dixyrazine combination. The serum concentration of desmethylclomipramine monotherapy was significantly higher and the side effects significantly lower in the combined treatment with dixyrazine than with clomipramine monotherapy. Clomipramine combined with dixyrazine seems superior to clomipramine in the treatment of panic disorder. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Psychiatrica Scandinavica Wiley

Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine

Loading next page...
 
/lp/wiley/increased-antipanic-efficacy-in-combined-treatment-with-clomipramine-WxHOiuLBU7

References (24)

Publisher
Wiley
Copyright
Copyright © 1994 Wiley Subscription Services
ISSN
0001-690X
eISSN
1600-0447
DOI
10.1111/j.1600-0447.1994.tb01506.x
Publisher site
See Article on Publisher Site

Abstract

A double‐blind 12 week trial was undertaken to compare the effects of clomipramine + dixyrazine with clomipramine + placebo in the treatment of panic disorder with or without agoraphobia. Of 45 patients included (21 dixyrazine, 24 placebo), 16 dropped out (6 dixyrazine, 10 placebo). The number of panic attacks and the scores on the panic disorder subscale of the Hamilton Anxiety Rating Scale were significantly reduced in response to both treatment regimens, but the reduction was significantly greater in the dixyrazine group. The patients’ daily functioning was significantly more improved with the dixyrazine combination. The serum concentration of desmethylclomipramine monotherapy was significantly higher and the side effects significantly lower in the combined treatment with dixyrazine than with clomipramine monotherapy. Clomipramine combined with dixyrazine seems superior to clomipramine in the treatment of panic disorder.

Journal

Acta Psychiatrica ScandinavicaWiley

Published: Jan 1, 1994

Keywords: ; ;

There are no references for this article.